Search

everythinglearnresearchcommunity

for

Search:↓

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Advanced microscopy shows hair damage and keratin proteins' roles, aiding future cosmetic treatments.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Understanding different types of skin cells, especially fibroblasts, can lead to better treatments for wound healing and less scarring.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Bio-based materials like hydrogels show promise in treating skin cancer with fewer side effects, but more research is needed.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Understanding SARS-CoV-2's spread and immune response is key to developing treatments and vaccines, but preventive measures remain important.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

The treatment combination is effective and generally safe for lung cancer.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

PRP is not a stem cell treatment and should not be marketed as such.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.